New RA Guidelines Emphasize Early Treatment

"When they do [occur], they can be very useful in identifying the disease, and they are important markers and predictors of disease severity and need for therapy," he said.

The guidelines also lack biomarkers for treatment response, he added.

Several of the guideline authors disclosed financial and other relationships with multiple pharmaceutical companies. Dr. Matteson stated that he had no financial disclosures relative to his comments.